{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T06:11:59Z","timestamp":1777443119823,"version":"3.51.4"},"reference-count":51,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1124\/jpet.104.065391","type":"journal-article","created":{"date-parts":[[2004,6,18]],"date-time":"2004-06-18T17:28:53Z","timestamp":1087579733000},"page":"326-333","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["FE200041 (d-Phe-d-Phe-d-Nle-d-Arg-NH2): A Peripheral Efficacious \u03ba Opioid Agonist with Unprecedented Selectivity"],"prefix":"10.1016","volume":"310","author":[{"given":"Todd W.","family":"Vanderah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio D.","family":"Schteingart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerzy","family":"Trojnar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Louis","family":"Junien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josephine","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre J.-M.","family":"Riviere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.104.065391_bib1","doi-asserted-by":"crossref","unstructured":"Ambo A, Adachi T, and Sasaki Y (1995) Synthesis and opioid activities of [D-Leu8] dynorphin (1-8) fragments containing a reduced peptide bond, \u03a8 (CH2NH). Chem Pharm Bull 43: 1547-1550.","DOI":"10.1248\/cpb.43.1547"},{"key":"10.1124\/jpet.104.065391_bib2","doi-asserted-by":"crossref","unstructured":"Bagnol D, Mansour A, Akil H, and Watson SJ (1997) Cellular localization and distribution of the cloned mu and kappa opioid receptors in rat gastrointestinal tract. Neuroscience 81: 579-591.","DOI":"10.1016\/S0306-4522(97)00227-3"},{"key":"10.1124\/jpet.104.065391_bib3","doi-asserted-by":"crossref","unstructured":"Barber A, Bartoszyk GD, Bender HM, Gottschlich R, Greiner HE, Harting J, Mauler F, Minck K-O, Murray RD, Simon M, et al. (1994) A pharmacological profile of the novel, peripherally-selective k-opioid receptor agonist, EMD 61753. Br J Pharmacol 113: 1317-1327.","DOI":"10.1111\/j.1476-5381.1994.tb17142.x"},{"key":"10.1124\/jpet.104.065391_bib4","doi-asserted-by":"crossref","unstructured":"Barber A and Gottschlich R (1992) Opioid agonists and antagonists: an evaluation of their peripheral actions in inflammation. Med Res Rev 12: 525-562.","DOI":"10.1002\/med.2610120505"},{"key":"10.1124\/jpet.104.065391_bib5","doi-asserted-by":"crossref","unstructured":"Barber A and Gottschlich R (1997) Novel developments with selective, non-peptidic kappa-opioid receptor agonists. Exp Opin Investig Drugs 6: 1351-1368.","DOI":"10.1517\/13543784.6.10.1351"},{"key":"10.1124\/jpet.104.065391_bib6","doi-asserted-by":"crossref","unstructured":"Catheline G, Guilbaud G, and Kayser V (1998) Peripheral component in the enhanced antinociceptive effect of systemic U-69,593, a \u03ba-opioid receptor agonist in mononeuropathic rats. Eur J Pharmacol 357: 171-178.","DOI":"10.1016\/S0014-2999(98)00597-4"},{"key":"10.1124\/jpet.104.065391_bib7","doi-asserted-by":"crossref","unstructured":"Chen Y, Mestek A, Liu J, Hurley J, and Yu L (1993) Molecular cloning and functional expression of a mu-opioid receptor from rat brain. Mol Pharmacol 44: 8-12.","DOI":"10.1016\/S0026-895X(25)13175-1"},{"key":"10.1124\/jpet.104.065391_bib8","doi-asserted-by":"crossref","unstructured":"Delgado-Aros S, Chial HJ, Camilleri M, Szarka LA, Weber FT, Jacob J, Ferber I, McKinzie S, Burton DD, and Zinsmeister AR (2002) Effects of a \u03ba-opioid agonist, asimadoline, on satiation and GI motor and sensory functions in humans. Am J Physiol 284: G558-G566.","DOI":"10.1152\/ajpgi.00360.2002"},{"key":"10.1124\/jpet.104.065391_bib9","doi-asserted-by":"crossref","unstructured":"Dickenson AH and Sullivan AF (1987) Subcutaneous formalin-induced activity of dorsal horn neurons in the rat: different responses to an intrathecal opiate administered pre- or post-formalin. Pain 30: 339-348.","DOI":"10.1016\/0304-3959(87)90023-6"},{"key":"10.1124\/jpet.104.065391_bib10","doi-asserted-by":"crossref","unstructured":"Dooley CT, Ny P, Bidlack JM, and Houghten RA (1998) Selective ligands for the \u03bc, \u03b4 and \u03ba opioid receptors identified from a single mixture based tetrapeptide positional scanning combinatorial library. J Biol Chem 273: 18848-18856.","DOI":"10.1074\/jbc.273.30.18848"},{"key":"10.1124\/jpet.104.065391_bib11","doi-asserted-by":"crossref","unstructured":"Dubuisson D and Dennis SG (1977) The formalin test: a quantitative study of the analgesic effects of morphine, meperidine and brain-stem stimulation in rats and cats. Pain 4: 161-174.","DOI":"10.1016\/0304-3959(77)90130-0"},{"key":"10.1124\/jpet.104.065391_bib12","doi-asserted-by":"crossref","unstructured":"Endoh T, Tajima A, Suzuki T, Kamei J, Suzuki T, Narita M, Tseng L, and Nagase H (2000) Characterization of the antinociceptive effects of TRK-820 in the rat. Eur J Pharmacol 387: 133-140.","DOI":"10.1016\/S0014-2999(99)00815-8"},{"key":"10.1124\/jpet.104.065391_bib13","doi-asserted-by":"crossref","unstructured":"Evans C, Keith JD, Morrison H, Magendzo K, and Edwards R (1992) Cloning of a delta opioid receptor by functional expression. Science (Wash DC) 258: 1952-1955.","DOI":"10.1126\/science.1335167"},{"key":"10.1124\/jpet.104.065391_bib14","doi-asserted-by":"crossref","unstructured":"Field MJ, Carnell AJ, Gonzalez MI, McCleary S, Oles RJ, Smith R, Hughes J, and Singh L (1999) Enadoline, a selective \u03ba-opioid receptor agonist shows potent antihyperalgesic and antiallodynic actions in a rat model of surgical pain. Pain 80: 383-389.","DOI":"10.1016\/S0304-3959(98)00237-1"},{"key":"10.1124\/jpet.104.065391_bib15","doi-asserted-by":"crossref","unstructured":"Gear RW, Gordon NC, Heller PH, Paul SM, Miaskowski C, and Levine JD (1996a) Gender differences in analgesic response to the kappa-opioid pentazocine. Neurosci Lett 205: 207-209.","DOI":"10.1016\/0304-3940(96)12402-2"},{"key":"10.1124\/jpet.104.065391_bib16","doi-asserted-by":"crossref","unstructured":"Gear RW, Miaskowski C, Gordon NC, Paul SM, Heller PH, and Levine JD (1996b) Kappa opioids produce significantly greater analgesia in women than men. Nat Med 2: 1248-1250.","DOI":"10.1038\/nm1196-1248"},{"key":"10.1124\/jpet.104.065391_bib17","doi-asserted-by":"crossref","unstructured":"Hargreaves K, Dubner R, Brown F, Flores C, and Joris J (1988) A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32: 77-88.","DOI":"10.1016\/0304-3959(88)90026-7"},{"key":"10.1124\/jpet.104.065391_bib18","doi-asserted-by":"crossref","unstructured":"Hiramatsu M, Inoue K, Ambo A, Sasaki Y, and Kameyama T (2001) Long-lasting antinociceptive effects of a novel dynorphin analogue, Tyr-D-Ala-Phe-Leu-Arg \u03a8 (CH2NH) Arg-NH2, in mice. Br J Pharmacol 132: 1948-1956.","DOI":"10.1038\/sj.bjp.0703982"},{"key":"10.1124\/jpet.104.065391_bib19","doi-asserted-by":"crossref","unstructured":"Horan P, Taylor J, Yamamura H, and Porreca F (1992) Extremely long-lasting antagonistic actions of nor-binaltorphimine (nor-BNI) in the mouse tail-flick test. J Pharmacol Exp Ther 260: 1237-1243.","DOI":"10.1016\/S0022-3565(25)11434-1"},{"key":"10.1124\/jpet.104.065391_bib20","doi-asserted-by":"crossref","unstructured":"Hughes J, Kosterlitz HW, and Leslie FM (1975) Effect of morphine on adrenergic transmission in the mouse vas deferens. Assessment of agonist and antagonist potencies of narcotic analgesics. Br J Pharmacol 53: 371-381.","DOI":"10.1111\/j.1476-5381.1975.tb07373.x"},{"key":"10.1124\/jpet.104.065391_bib21","doi-asserted-by":"crossref","unstructured":"Hunter JC, Leighton GE, Meecham KG, Boyle SJ, Horwell DC, Rees DC, and Hughes J (1990) CI-977, a novel and selective agonist for the kappa-opioid receptor. Br J Pharmacol 101: 183-189.","DOI":"10.1111\/j.1476-5381.1990.tb12110.x"},{"key":"10.1124\/jpet.104.065391_bib22","unstructured":"Jiang Q, Heyman JS, and Porreca F (1989) Mu antagonist and kappa agonist properties of \u03b2-funaltrexamine (\u03b2-FNA): long lasting spinal antinociception. NIDA Res Monogr 95: 199-205."},{"key":"10.1124\/jpet.104.065391_bib23","doi-asserted-by":"crossref","unstructured":"Junien JL and Wettstein JG (1992) Role of opioids in peripheral analgesia. Life Sci 51: 2009-2018.","DOI":"10.1016\/0024-3205(92)90150-N"},{"key":"10.1124\/jpet.104.065391_bib24","doi-asserted-by":"crossref","unstructured":"Kamp EH, Carter R, Jones W, Tillman SR, and Gebhart GF (2003) Quantitative assessment and characterization of visceral nociception and hyperalgesia in mice. Am J Physiol 284: G434-G444.","DOI":"10.1152\/ajpgi.00324.2002"},{"key":"10.1124\/jpet.104.065391_bib25","doi-asserted-by":"crossref","unstructured":"Kieffer B, Befort K, Gaveriaux-Ruff C, and Hirth C (1992) The delta opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. Proc Natl Acad Sci USA 89: 12048-12052.","DOI":"10.1073\/pnas.89.24.12048"},{"key":"10.1124\/jpet.104.065391_bib26","doi-asserted-by":"crossref","unstructured":"Lai J, Ma SW, Zhu RH, Rothman RB, Lentes KU, and Porreca F (1994) Pharmacological characterization of the cloned kappa opioid receptor as a kappa 1b subtype. Neuroreport 5: 2161-2164.","DOI":"10.1097\/00001756-199410270-00043"},{"key":"10.1124\/jpet.104.065391_bib27","doi-asserted-by":"crossref","unstructured":"Lorenzen A, Fuss M, Vogt H, and Schwabe U (1993) Measurement of guanine nucleotide-binding protein activation by A1 adenosine receptor agonists in bovine brain membranes: stimulation of guanosine-5\u2032-O-(3-[35S]thio)triphosphate binding. Mol Pharmacol 44: 115-123.","DOI":"10.1016\/S0026-895X(25)13117-9"},{"key":"10.1124\/jpet.104.065391_bib28","doi-asserted-by":"crossref","unstructured":"Machelska H, Pfluger M, Weber W, Piranvisseh-Volk M, Daubert JD, Dehaven R, and Stein C (1999) Peripheral effects of the \u03ba-opioid agonist EMD 61753 on pain and inflammation in rats and humans. J Pharmacol Exp Ther 290 1: 354-361.","DOI":"10.1016\/S0022-3565(24)34907-9"},{"key":"10.1124\/jpet.104.065391_bib29","doi-asserted-by":"crossref","unstructured":"Marchand F, Ardid D, Chapuy E, Alloui A, Jourdan D, and Eschalier A (2003) Evidence for an involvement of supraspinal \u03b4- and spinal \u03bc-opioid receptors in the antihyperalgesia effect of chronically administered clomipramine in mononeuropathic rats. J Pharmacol Exp Ther 307: 268-274.","DOI":"10.1124\/jpet.103.052613"},{"key":"10.1124\/jpet.104.065391_bib30","doi-asserted-by":"crossref","unstructured":"Martin WR, Eades CG, Thompson JA, Huppler RE, and Gilbert PE (1976) The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J Pharmacol Exp Ther 197: 517-532.","DOI":"10.1016\/S0022-3565(25)30536-7"},{"key":"10.1124\/jpet.104.065391_bib31","doi-asserted-by":"crossref","unstructured":"Meng F, Xie G-X, Thompson R, Mansour A, Goldstein A, Watson SJ, and Akil H (1993) Cloning and pharmacological characterization of a rat kappa opioid receptor. Proc Natl Acad Sci USA 90: 9954-9958.","DOI":"10.1073\/pnas.90.21.9954"},{"key":"10.1124\/jpet.104.065391_bib32","doi-asserted-by":"crossref","unstructured":"Nicholson AN (1987) New antihistamines free of sedative side-effects. Trends Pharmacol Sci 8: 247-249.","DOI":"10.1016\/0165-6147(87)90192-1"},{"key":"10.1124\/jpet.104.065391_bib33","doi-asserted-by":"crossref","unstructured":"Pande AC, Pyke RE, Greiner M, Cooper SA, Benjamin R, and Pierce MW (1996) Analgesic efficacy of the kappa-receptor agonist, enadoline, in dental surgery pain. Clin Neuropharmacol 19: 92-97.","DOI":"10.1097\/00002826-199619010-00009"},{"key":"10.1124\/jpet.104.065391_bib34","doi-asserted-by":"crossref","unstructured":"Pasternak GW (1993) Pharmacological mechanism of opioid analgesia. Clin Neuropharmacol 16: 1-18.","DOI":"10.1097\/00002826-199302000-00001"},{"key":"10.1124\/jpet.104.065391_bib35","doi-asserted-by":"crossref","unstructured":"Pfeiffer A, Brantl V, Herz A, and Emrich HM (1986) Psychotomimesis mediated by kappa opiate receptors. Science (Wash DC) 233: 774-776.","DOI":"10.1126\/science.3016896"},{"key":"10.1124\/jpet.104.065391_bib36","doi-asserted-by":"crossref","unstructured":"Portoghese PS, Lipkowski AW, and Takemori AE (1987) Bimorphinans as highly selective potent kappa receptor antagonists. J Med Chem 30: 238-239.","DOI":"10.1021\/jm00385a002"},{"key":"10.1124\/jpet.104.065391_bib37","doi-asserted-by":"crossref","unstructured":"Przewlocki R and Przewlocka B (2001) Opioids in chronic pain. Eur J Pharmacol 429: 79-91.","DOI":"10.1016\/S0014-2999(01)01308-5"},{"key":"10.1124\/jpet.104.065391_bib38","doi-asserted-by":"crossref","unstructured":"Rogers H, Birch PJ, Harrison SM, Palmer E, Manchee GR, Judd DB, Naylor A, Scopes DIC, and Hayes AG (1992) GR 94839, a \u03ba-opioid agonist with limited access to the central nervous system, has antinociceptive activity. Br J Pharmacol 106: 783-789.","DOI":"10.1111\/j.1476-5381.1992.tb14413.x"},{"key":"10.1124\/jpet.104.065391_bib39","doi-asserted-by":"crossref","unstructured":"Shaw JS, Carroll JA, Alcoc P, and Main BG (1989) ICI 204448: a \u03ba-opioid agonist with limited access to the CNS. Br J Pharmacol 96: 986-992.","DOI":"10.1111\/j.1476-5381.1989.tb11911.x"},{"key":"10.1124\/jpet.104.065391_bib40","doi-asserted-by":"crossref","unstructured":"Simonin F, Gaveriaux-Ruff C, Befort K, Matthes H, Lannes B, Micheletti G, Mattei M-G, Charron G, Bloch B, and Kieffer B (1995) \u03ba-opioid receptor in humans: cDNA and genomic cloning, chromosomal assignment, functional expression, pharmacology and expression pattern in the central nervous system. Proc Natl Acad Sci USA 92: 7006-7010.","DOI":"10.1073\/pnas.92.15.7006"},{"key":"10.1124\/jpet.104.065391_bib41","doi-asserted-by":"crossref","unstructured":"Spetea M, Rydelius G, Nylander I, Ahmed M, Bileviciute-Ljungar I, Lundeberg T, Svensson S, and Kreieberg A (2002) Alteration in endogenous opioid systems due to chronic inflammatory pain conditions. Eur J Pharmacol 435: 245-252.","DOI":"10.1016\/S0014-2999(01)01554-0"},{"key":"10.1124\/jpet.104.065391_bib42","doi-asserted-by":"crossref","unstructured":"Stein C (1993) Peripheral mechanisms of opioid analgesia. Anesth Analg 76: 182-191.","DOI":"10.1213\/00000539-199301000-00031"},{"key":"10.1124\/jpet.104.065391_bib43","unstructured":"Tachibana S, Yoshino H, Arakawa Y, Nakazawa T, Kaneko T, Yamatsu K, and Miyagawa H (1988) Design and synthesis of metabolically stable analogues of dynorphin A and their analgesic characteristics, in Biowarning System in the Brain (Takagi H, Oomura Y, Ito M, and Otsuka M eds) pp 101-109, University of Tokyo Press, Tokyo."},{"key":"10.1124\/jpet.104.065391_bib44","doi-asserted-by":"crossref","unstructured":"Thompson RC, Mansour A, Akil H, and Watson SJ (1993) Cloning and pharmacological characterization of a rat m opioid receptor. Neuron 11: 903-913.","DOI":"10.1016\/0896-6273(93)90120-G"},{"key":"10.1124\/jpet.104.065391_bib45","doi-asserted-by":"crossref","unstructured":"Walker J, Catheline G, Guilbaud G, and Kayser V (1999) Lack of cross-tolerance between the antinociceptive effects of systemic morphine and asimadoline, a peripherally-selective \u03ba-opioid agonist, in CCI-neuropathic rats. Pain 83: 509-516.","DOI":"10.1016\/S0304-3959(99)00158-X"},{"key":"10.1124\/jpet.104.065391_bib46","doi-asserted-by":"crossref","unstructured":"Wheeler-Aceto H and Cowan A (1991) Standardization of the rat paw formalin test for the evaluation of analgesics. Psycopharmacology 104: 35-44.","DOI":"10.1007\/BF02244551"},{"key":"10.1124\/jpet.104.065391_bib47","doi-asserted-by":"crossref","unstructured":"Wilson JL, Carmody JJ, and Walker JS (2000) The importance of the hypothalamo-hypophyseal-adrenal axis to the anti-inflammatory actions of the \u03ba-opioid agonist PNU-U50,488H in rats with adjuvant arthritis. J Pharmacol Exp Ther 294: 1131-1136.","DOI":"10.1016\/S0022-3565(24)39181-5"},{"key":"10.1124\/jpet.104.065391_bib48","doi-asserted-by":"crossref","unstructured":"Wilson JL, Nayanar V, and Walker JS (1996) The site of anti-arthritic action of the kappa agonist, U50,488H: importance of local administration. Br J Pharmacol 118: 1754-1760.","DOI":"10.1111\/j.1476-5381.1996.tb15601.x"},{"key":"10.1124\/jpet.104.065391_bib49","doi-asserted-by":"crossref","unstructured":"Yasuda K, Raynor K, Kong H, Breder CD, Takeda J, Reisine T, and Bell GI (1993) Cloning and functional comparison of k and d opioid receptors from mouse brain. Proc Natl Acad Sci USA 90: 6736-6740.","DOI":"10.1073\/pnas.90.14.6736"},{"key":"10.1124\/jpet.104.065391_bib50","doi-asserted-by":"crossref","unstructured":"Yu J, Butelman ER, Woods JH, Chait BT, and Kreek MJ (1997) Dynorphin A (1\u20138) analog, E-2078, crosses the blood-brain barrier in rhesus monkeys. J Pharmacol Exp Ther 282: 633-638.","DOI":"10.1016\/S0022-3565(24)36864-8"},{"key":"10.1124\/jpet.104.065391_bib51","doi-asserted-by":"crossref","unstructured":"Zhu J, Chen C, Xue J-C, Kunapuli S, DeRiel K, and Liu-Chen L-Y (1995) Cloning of a human \u03ba opioid receptor from the brain. Pharmacol Lett 56: PL201-PL207.","DOI":"10.1016\/0024-3205(94)00507-O"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524314429?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524314429?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.104.065391","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T20:55:46Z","timestamp":1739998546000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524314429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["S0022356524314429"],"URL":"https:\/\/doi.org\/10.1124\/jpet.104.065391","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2004,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FE200041 (d-Phe-d-Phe-d-Nle-d-Arg-NH2): A Peripheral Efficacious \u03ba Opioid Agonist with Unprecedented Selectivity","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.104.065391","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2004 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}